date:Oct 11, 2012
Vitamin and nutritional supplement manufacturer NBTY has revealed in a financial guidance statement that it will post sales of over $3 billion for the year ending 30 September.
NBTY said that sales would hit $3.05 billion to $3.07 billion for the fiscal 2012. Consolidated EBITDA is expected to be between $556 million and $566 million while capital expenditure is estimated to reach $90-95 million.
Total debt to the end of September stood at $2.158 million. The firm will announce its full-year r